Related Experiment Video
Updated: Jun 3, 2026
06:45
A Mouse Model of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Procedure Aided by Microscopy
Published on: January 19, 2024
Split-liver procedure and inflammatory response: improvement by pharmacological preconditioning.
Maximilian von Heesen1, Matthias Hülser, Katharina Seibert
1Department of General, Vascular and Pediatric Surgery, University of Saarland, Homburg/Saar, Germany.
The Journal of Surgical Research
|March 26, 2011
Summary
Pharmacologic preconditioning improves split-liver transplant outcomes by reducing inflammation and preserving graft quality. This approach mitigates the negative effects of the split-liver procedure, enhancing donor liver viability.
Area of Science:
- Hepatobiliary surgery
- Transplantation immunology
- Pharmacology
Background:
- Split-liver (SL) transplantation outcomes are compromised by vascular complications and primary non-function.
- The in situ SL procedure may trigger inflammatory responses and degrade graft quality.
- Investigating pharmacologic preconditioning to enhance graft quality is crucial.
Purpose of the Study:
- To investigate the impact of an in situ split-liver procedure on graft quality and inflammatory response.
- To evaluate the efficacy of a pharmacologic preconditioning protocol (HPP) in mitigating these negative effects.
Main Methods:
- Split-liver procedures were performed in a rat model.
- One group received Homburg preconditioning protocol (HPP) with multiple agents; a control group received saline.
- Cytokine release, leukocyte infiltration, endothelial activation, and liver/lung morphology were assessed.
Main Results:
- The SL procedure increased TNF-α, ICAM-1 expression, leukocyte infiltration, and hepatocyte apoptosis.
- HPP significantly reduced these inflammatory markers and improved graft cell viability.
- Remote lung injury markers (IL-1, IL-6) were also elevated in the SL group.
Conclusions:
- Homburg preconditioning protocol (HPP) effectively abrogated the cytokine-mediated leukocytic response post-SL procedure.
- Pharmacologic preconditioning of liver donors can prevent SL procedure-induced inflammation.
- This preconditioning strategy leads to improved graft quality in split-liver transplantation.
